Cargando…
Vaccine Therapies for Cancer: Then and Now
There are strong biologic and preclinical rationales for the development of therapeutic cancer vaccines; however, the clinical translation of this treatment strategy has been challenging. It is now understood that many previous clinical trials of cancer vaccines used target antigens or vaccine desig...
Autores principales: | Morse, Michael A., Gwin, William R., Mitchell, Duane A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845582/ https://www.ncbi.nlm.nih.gov/pubmed/33512679 http://dx.doi.org/10.1007/s11523-020-00788-w |
Ejemplares similares
-
Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
por: Sayour, Elias J., et al.
Publicado: (2017) -
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018) -
Translational nanoparticle engineering for cancer vaccines
por: Grippin, Adam J., et al.
Publicado: (2017) -
Hormone Therapy and Risk of Breast Cancer: Where Are We Now?
por: Micha, John P., et al.
Publicado: (2022) -
Mucosal vaccines: wisdom from now and then
por: Kiyono, Hiroshi, et al.
Publicado: (2021)